---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-029034"
form_type: "8-K"
ticker: "ULBI"
cik: "0000875657"
company_name: "ULTRALIFE CORP"
filed_at: "2023-10-26T23:59:59+00:00"
generated_at: "2026-06-09T09:24:51.542367+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ultralife Q3 sales $39.5M (+18.8% YoY); operating income $2.1M vs loss

## Summary
- GAAP net income $1.3M ($0.08 diluted EPS) vs net loss of $0.2M a year ago.
- Adjusted EPS $0.10 vs adjusted loss of $0.03 in Q3 2022.
- Gross margin improved 460 bps to 24.8% on price realization and level-loaded production.
- Government/defense sales up 48.1%; commercial sales up 5.6%.
- Backlog $101.1M at quarter-end, with over $35M expected to ship in remaining 2023.

## SEC filing metadata
- accession: 0001437749-23-029034
- form_type: 8-K
- ticker: ULBI
- cik: 0000875657
- company_name: ULTRALIFE CORP
- filed_at: 2023-10-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/875657/000143774923029034/0001437749-23-029034-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/875657/000143774923029034/ulbi20231025_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-029034
- JSON: https://secwatch.observer/filing/0001437749-23-029034.json
- Plain text: https://secwatch.observer/filing/0001437749-23-029034.txt

## Key facts
- Earnings Releases
  ULTRALIFE CORP reported third quarter ended September 30, 2023 results: revenue $39.5 million, net income $1.3 million or $0.08 per diluted share, EPS $0.08 per diluted share.
  - Period: third quarter ended September 30, 2023
  - Revenue: $39.5 million
  - Net income: $1.3 million or $0.08 per diluted share
  - EPS: $0.08 per diluted share
  - Result: reported results
  source text: – October 26, 2023 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the third quarter ended September 30, 2023 with the following highlights: ● Sales of $39.5 million representing an 18.8% year-over-year increase ● Operating income of $2.1 million versus a loss of $0.6 million for the 2022 third quarter ● Adjusted EPS of $0.10 compared to a
  evidence_url: https://www.sec.gov/Archives/edgar/data/875657/000143774923029034/0001437749-23-029034-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.